Neuromodulation refers to the process by which the activity of neurons in the nervous system is regulated through various mechanisms. Unlike neurotransmitters, which act on specific receptors to produce rapid synaptic transmission, neuromodulators exert their effects over longer time scales and can influence the activity of multiple neurons simultaneously. This modulation can occur at various levels within the nervous system, including the synapse, neuronal circuits, and even entire brain regions. Neuromodulators can be broadly classified into endogenous substances, such as neurotransmitters that also have modulatory effects (e.g., dopamine, serotonin), and exogenous substances, which are artificially introduced into the nervous system to modulate neural activity (e.g., electrical stimulation, pharmacological agents). The effects of neuromodulation can range from altering the excitability of neurons to influencing synaptic plasticity, which underlies learning and memory processes. This field has significant implications for both basic neuroscience research and clinical applications. In research, neuromodulation techniques are employed to dissect the complex interactions within neuronal circuits and understand how these circuits give rise to behavior and cognition. In the clinical realm, neuromodulation therapies are used to treat various neurological and psychiatric disorders, including chronic pain, Parkinson's disease, depression, and epilepsy. Examples of therapies involving neuromodulation encompass deep brain stimulation, transcranial magnetic stimulation, and spinal cord stimulation.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States